Buprenorphine Transdermal System 58064-0408-04
Generic: Buprenorphine
- Manufacturer
- Lts Therapy Systems, Llc
- Dosage Form
- Patch, Extended Release
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- May 17, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA207490
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine | 20 ug/h |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
58064-0408-04Selected4 POUCH in 1 CARTON (58064-408-04) / 1 PATCH in 1 POUCH (58064-408-11) / 168 h in 1 PATCH